REAL-WORLD DURVALUMAB IN EXTENSIVE-STAGE SMALL CELL LUNG CANCER

Trial Identifier: D9070R00001
Sponsor: AstraZeneca
Start Date: July 2024
Primary Completion Date: December 2025
Study Completion Date: December 2025
Condition: Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Italy, Italy Bologna, Italy, Italy
Italy, Italy Catanzaro, Italy, Italy
Italy, Italy Lucca, Italy, Italy
Italy, Italy Napoli, Italy, Italy
Italy, Italy Palermo, Italy, Italy
Italy, Italy Pistoia, Italy, Italy
Italy, Italy Prato, Italy, Italy
Italy, Italy Roma, Italy, Italy
Italy, Italy Trento, Italy, Italy
Italy, Italy Varese, Italy, Italy
Italy, Italy Vimercate, Italy, Italy